Cancer registration in developing countries: luxury or necessity?

This is the title of an article in the Lancet Oncology - free to read after registration due to the nature of the topic: linked here

There are several benefits which may accrue to developed nations who are willing to help with the process and technology of registration in the developing world - facilitating the conduct of clinical trials has multiple benefits including helping developed nations better treat their citizens whose immediate parentage links them to developing nations - observations made on significantly larger populations sizes than may be available in the developed nations can lead to better tailored treatment for those of e.g. East African origin living in e.g. the United Kingdom.

This is why we have been working recently with the International Network for Cancer Treatment and Research (INCTR) to develop resources which will benefit those working in cancer control in the developing world.

Thanks to the INCTR for tweeting this article - retweeted by us - see recent tweets!

B5